1. Al Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS, Balducci L, McCracker J, Padilla F (1982) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma. A Southwest Oncology Group study. Cancer Treat Rep 66: 31
2. Anand AJ, Bashey B (1993) Newer insights into cisplatin toxicity. Ann Pharmacother 27: 1519
3. Baldew GS, McVie JG, Van Der Valk MA, Los G, De Goeij JJM, Vermeulen NPE (1990) Selective reduction in thecis-diamminedichloroplatinum(II) nephrotoxicity by ebselen. Cancer Res 50: 7031
4. Belt RJ, Himmelstein KJ, Patton TF, Bannister SJ, Sterson LA, Repta AJ (1979) Pharmacokinetics of non protein-bound platinum species following administration ofcis-diamminedichloroplatinum(II). Cancer Treat Rep 63: 1515
5. Berry JM, Jacobs C, Sikic B, Halsey J, Borch RF (1990) Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 8: 1585